These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31012189)

  • 21. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
    Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
    Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
    Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
    Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERα positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells.
    Shi JF; Li XJ; Si XX; Li AD; Ding HJ; Han X; Sun YJ
    Biochem Biophys Res Commun; 2012 Oct; 427(1):47-53. PubMed ID: 22975348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated MEK/ERK Pathway Drives Widespread and Coordinated Overexpression of UHRF1 and DNMT1 in Cancer cells.
    Li J; Wang R; Hu X; Gao Y; Wang Z; Li J; Wong J
    Sci Rep; 2019 Jan; 9(1):907. PubMed ID: 30696879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα+ breast cancer MCF-7 cells.
    Rieber M; Strasberg-Rieber M
    Biochem Pharmacol; 2014 Mar; 88(2):169-77. PubMed ID: 24486524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells.
    Zheng N; Zhang P; Huang H; Liu W; Hayashi T; Zang L; Zhang Y; Liu L; Xia M; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2015 Jul; 128(3):97-107. PubMed ID: 26117209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-translational modification of OCT4 in breast cancer tumorigenesis.
    Cho Y; Kang HG; Kim SJ; Lee S; Jee S; Ahn SG; Kang MJ; Song JS; Chung JY; Yi EC; Chun KH
    Cell Death Differ; 2018 Nov; 25(10):1781-1795. PubMed ID: 29511337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
    Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OCT4 maintains self-renewal and reverses senescence in human hair follicle mesenchymal stem cells through the downregulation of p21 by DNA methyltransferases.
    Lu Y; Qu H; Qi D; Xu W; Liu S; Jin X; Song P; Guo Y; Jia Y; Wang X; Li H; Li Y; Quan C
    Stem Cell Res Ther; 2019 Jan; 10(1):28. PubMed ID: 30646941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.
    Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
    J Cell Biochem; 2011 Jan; 112(1):217-24. PubMed ID: 21069738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Investigation of Genes Regulated by ERα in Breast Cancer Cells.
    Wang S; Li X; Zhang W; Gao Y; Zhang K; Hao Q; Li W; Wang Z; Li M; Zhang W; Zhang Y; Zhang C
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30301189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
    Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
    Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
    Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
    Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
    Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
    Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
    Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
    Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
    Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
    Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
    Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
    Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.